The global ambulatory blood pressure monitoring (ABPM) devices market size was valued at USD 1,387.53 million in 2024. It is expected to grow from USD 1,542.87 million in 2025 to USD 4,099.35 million by 2034, at a CAGR of 11.5% during 2025–2034.
Market Overview
Ambulatory blood pressure monitoring devices are non-invasive tools that measure blood pressure at regular intervals over 24 hours, providing a comprehensive profile of a patient's blood pressure fluctuations throughout the day and night. Unlike traditional clinical measurements, ABPM offers more accurate and predictive data, aiding in the diagnosis and management of hypertension and related cardiovascular conditions.
The escalating global burden of hypertension, affecting over 1.28 billion adults aged 30 to 79 years, underscores the critical need for effective monitoring solutions . ABPM devices play a pivotal role in early detection, enabling timely interventions and reducing the risk of complications such as stroke and heart attack.
Market Segmentation
By Device Type:
- Arm ABPM Devices: These devices are widely used in clinical settings due to their high accuracy and reliability.
- Wrist ABPM Devices: Offering convenience and portability, wrist monitors are gaining popularity for home-based monitoring.
By Operation:
- Automatic: Fully automated devices that require minimal user intervention, enhancing user compliance.
- Semi-Automatic: Devices that combine manual and automatic features, offering flexibility in usage.
- Manual: Traditional devices operated manually, primarily used in specific clinical scenarios.
By End-Use:
- Hospitals and Clinics: Primary users of ABPM devices for patient diagnosis and management.
- Ambulatory Surgical Centers (ASCs): Utilize ABPM devices for pre- and post-operative monitoring.
- Home Care Settings: Increasing adoption due to the rise in home-based healthcare and patient preference for self-monitoring.
Regional Analysis
North America:
North America dominated the global ABPM devices market with a revenue share of 39.6% in 2023 . The United States, accounting for 87.4% of the regional market, is witnessing growth driven by the high prevalence of heart diseases and hypertension, coupled with technological advancements and increased healthcare expenditure.
Europe:
Europe holds the second-largest market share, attributed to the rising geriatric population and growing awareness about the benefits of 24-hour blood pressure monitoring. Countries like Germany, the UK, and France are leading the adoption of ABPM devices, supported by robust healthcare infrastructure and favorable reimbursement policies.
Asia Pacific:
Asia Pacific is anticipated to witness significant growth with a CAGR of 13.4% during the forecast period . Factors such as favorable government initiatives, increasing healthcare expenditure, and a growing geriatric population are propelling market expansion in countries like China, India, and Japan.
Latin America:
The Latin American market is projected to grow due to the rising number of people living with chronic diseases and cardiac disorders. Countries like Brazil and Mexico are focusing on strengthening primary care and monitoring services, contributing to the adoption of digital BP monitoring products.
Middle East and Africa:
The Middle East and Africa region is expected to experience steady growth, driven by increasing healthcare awareness, improving healthcare infrastructure, and a rising burden of hypertension and cardiovascular diseases.
Key Companies
The global ABPM devices market is characterized by the presence of several key players focusing on innovation and strategic collaborations to enhance their market position. Prominent companies include:
- Omron Healthcare
- GE Healthcare
- Schiller AG
- Bosch + Sohn GmbH
- Microlife Corporation
- Contec Medical Systems Co., Ltd
- BPL Ltd
- Halma Plc
- Vaso Corporation
These companies are investing in research and development to introduce advanced ABPM devices with improved accuracy, user-friendliness, and integration with digital health platforms.
Conclusion
The ambulatory blood pressure monitoring devices market is poised for substantial growth, driven by the increasing prevalence of hypertension, technological advancements, and a shift towards preventive healthcare. As awareness about the importance of continuous blood pressure monitoring rises, and healthcare systems globally emphasize early diagnosis and management of cardiovascular conditions, the demand for ABPM devices is expected to escalate.
More Trending Latest Reports By Polaris Market Research:
Human Immunodeficiency Virus (HIV) Drugs Market
Advanced Wound Care Management Market
Age-Related Macular Degeneration (AMD) Market
